Skip to main content

Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers

Legal

Privacy Policy Terms of Service About Our Crawler Content Removal Your Privacy Choices

© 2026 Formulate. Pharma Jobs with Drug Intelligence.

argenx Jobs | Formulate

Jobs
argenx

argenx Jobs

Belgium - Zwijnaarde

Biotechnology

argenx is a life sciences company focused on Antibody therapies.

47 open positions at argenx

View Full Profile

Filters:Immunology ×

Vice President, Business Planning and Readiness

argenx

Posted 1mo ago

Boston, MA, USA

$280K - $385K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyExecutive

H-1B · 1 FY23

Digital Technology Innovation Graduate

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Biomarker Biostatistics Lead

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Clinical Quality Lead

argenx

Posted 1mo ago

Remote

$152K - $209K

Full-time

Human Factors Expert

argenx

Posted 1mo ago

Gent, Belgium; Boston, MA, USA

Full-time

Senior Safety Medical Evidence & Insights Lead

argenx

Posted 1mo ago

Remote

Full-time

Director of Medical Writing

argenx

Posted 1mo ago

Remote

$212K - $292K

Full-time

Global FP&A Operations Lead

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Reporting & Insights Lead

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Sr Manager, Medical Review Operations

argenx

Posted 1mo ago

Remote

$140K - $193K

Full-time

Senior Scientist CMC

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Director, Regulatory CMC Device Leader

argenx

Posted 1mo ago

Gent

Full-time

Security Awareness and Education Lead

argenx

Posted 1mo ago

Remote

Full-time

Safety Scientist

argenx

Posted 2mo ago

Remote

$192K - $264K

Full-time

Medical Safety Lead

argenx

Posted 2mo ago

Remote

$292K - $402K

Full-time

Tax Manager

argenx

Posted 2mo ago

Boston, MA, USA

$96K - $132K

Full-time

Senior Medical Writer

argenx

Posted 2mo ago

Remote

$128K - $176K

Full-time

Associate Director, Medical Writing

argenx

Posted 2mo ago

Remote

$164K - $226K

Full-time

Toxicologist late stage clinical development and established Assets

argenx

Posted 2mo ago

Gent, Belgium

Full-time

Managed Markets/Gross to Net Finance Director

argenx

Posted 2mo ago

Boston, MA, USA

$176K - $242K

Full-time

Previous
1
2
3

Company Overview

Active Jobs

50

Pipeline Programs

86

Drug Products

2

Clinical Trials

83

View Full Company Profile

Therapeutic Areas

Neurology Immunology Oncology

Links

Company Website Careers Page

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyINTERN

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Data ScienceImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical WritingImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

FinanceImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Research & DevelopmentImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Regulatory AffairsImmunologyExecutive

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteResearch & DevelopmentImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMANAGER

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical WritingImmunologySenior

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical WritingImmunologyEntry

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Clinical OperationsImmunologyMID

H-1B · 1 FY23

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

FinanceImmunologyExecutive

H-1B · 1 FY23